Metronidazole METRONIDAZOLE AUROBINDO PHARMA LIMITED FDA Approved Metronidazole topical cream contains metronidazole, USP, at a concentration of 7.5 mg per gram (0.75%) in an emollient cream consisting of benzyl alcohol, emulsifying wax, glycerin, isopropyl palmitate, lactic acid and sodium hydroxide to adjust pH, purified water and sorbitol solution. Metronidazole is a member of the imidazole class of antibacterial agents and is classified therapeutically as an antiprotozoal and antibacterial agent. Chemically, metronidazole is 2-methyl-5-nitro-1 H -imidazole-1-ethanol. The molecular formula is C 6 H 9 N 3 O 3 and molecular weight is 171.16. Metronidazole is represented by the following structural formula: str
FunFoxMeds box
Substance Metronidazole
Route
TOPICAL
Applications
ANDA219295
Package NDC

Drug Facts

Composition & Profile

Strengths
0.75 % 45 g
Quantities
500 count
Treats Conditions
Indications And Usage Metronidazole Topical Cream Is Indicated For Topical Application In The Treatment Of Inflammatory Papules And Pustules Of Rosacea

Identifiers & Packaging

Container Type BOX
All Product Codes
UPC
0359651770467
UNII
140QMO216E
Packaging

HOW SUPPLIED: Metronidazole Topical Cream, 0.75% is supplied in a: 45 g aluminum tube NDC 59651-770-46 Storage conditions : Store at 20° to 25°C (68° to 77°F); excursions permitted to 15° to 30°C (59° to 86°F) [See USP Controlled Room Temperature]. Distributed by: Aurobindo Pharma USA, Inc. 279 Princeton-Hightstown Road East Windsor, NJ 08520 Manufactured by: Aurobindo Pharma Limited Hyderabad-500 032, India Issued: March 2025; PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 45 g Tube Label NDC 59651-770-46 Rx only Metronidazole Topical Cream 0.75% FOR TOPICAL USE ONLY. NOT FOR OPHTHALMIC USE. AUROBINDO NET WT. 45 g PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 45 g Tube Label; PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 45 g Tube Carton NDC 59651-770-46 Rx only Metronidazole Topical Cream 0.75% FOR TOPICAL USE ONLY. NOT FOR OPHTHALMIC USE. AUROBINDO NET WT. 45 g PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 45 g Tube Carton

Package Descriptions
  • HOW SUPPLIED: Metronidazole Topical Cream, 0.75% is supplied in a: 45 g aluminum tube NDC 59651-770-46 Storage conditions : Store at 20° to 25°C (68° to 77°F); excursions permitted to 15° to 30°C (59° to 86°F) [See USP Controlled Room Temperature]. Distributed by: Aurobindo Pharma USA, Inc. 279 Princeton-Hightstown Road East Windsor, NJ 08520 Manufactured by: Aurobindo Pharma Limited Hyderabad-500 032, India Issued: March 2025
  • PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 45 g Tube Label NDC 59651-770-46 Rx only Metronidazole Topical Cream 0.75% FOR TOPICAL USE ONLY. NOT FOR OPHTHALMIC USE. AUROBINDO NET WT. 45 g PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 45 g Tube Label
  • PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 45 g Tube Carton NDC 59651-770-46 Rx only Metronidazole Topical Cream 0.75% FOR TOPICAL USE ONLY. NOT FOR OPHTHALMIC USE. AUROBINDO NET WT. 45 g PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 45 g Tube Carton

Overview

Metronidazole topical cream contains metronidazole, USP, at a concentration of 7.5 mg per gram (0.75%) in an emollient cream consisting of benzyl alcohol, emulsifying wax, glycerin, isopropyl palmitate, lactic acid and sodium hydroxide to adjust pH, purified water and sorbitol solution. Metronidazole is a member of the imidazole class of antibacterial agents and is classified therapeutically as an antiprotozoal and antibacterial agent. Chemically, metronidazole is 2-methyl-5-nitro-1 H -imidazole-1-ethanol. The molecular formula is C 6 H 9 N 3 O 3 and molecular weight is 171.16. Metronidazole is represented by the following structural formula: str

Indications & Usage

: Metronidazole topical cream is indicated for topical application in the treatment of inflammatory papules and pustules of rosacea.

Dosage & Administration

: Apply and rub in a thin layer of metronidazole topical cream twice daily, morning and evening, to entire affected areas after washing. Areas to be treated should be washed with a mild cleanser before application. Patients may use cosmetics after application of metronidazole topical cream.

Warnings & Precautions
No warnings available yet.
Contraindications

: Metronidazole topical cream is contraindicated in individuals with a history of hypersensitivity to metronidazole, or other ingredients of the formulation.

Adverse Reactions

In controlled clinical trials, the total incidence of adverse reactions associated with the use of metronidazole topical cream was approximately 10%. Skin discomfort (burning and stinging) was the most frequently reported event followed by erythema, skin irritation, pruritus and worsening of rosacea. All individual events occurred in less than 3% of patients. The following additional adverse experiences have been reported with the topical use of metronidazole: dryness, transient redness, metallic taste, tingling or numbness of extremities and nausea. To report SUSPECTED ADVERSE REACTIONS, contact Aurobindo Pharma USA, Inc. at 1-866-850-2876 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

Drug Interactions

Oral metronidazole has been reported to potentiate the anticoagulant effect of warfarin and coumarin anticoagulants, resulting in a prolongation of prothrombin time. The effect of topical metronidazole on prothrombin time is not known.


Similar Drugs

Related medications based on brand, generic name, substance, active ingredients.

View all similar drugs →